Drug Shortage Report for PMS-ESCITALOPRAM
Report ID | 204508 |
Drug Identification Number | 02469251 |
Brand name | PMS-ESCITALOPRAM |
Common or Proper name | ESCITALOPRAM |
Company Name | PHARMASCIENCE INC |
Market Status | MARKETED |
Active Ingredient(s) | ESCITALOPRAM |
Strength(s) | 20MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 30 |
ATC code | N06AB |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-09-15 |
Estimated end date | 2025-07-24 |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2024-10-17 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6111 ROYALMOUNT AVE MONTREAL, QUEBEC CANADA H4P 2T4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2024-10-17 | French | Compare |
v12 | 2024-10-17 | English | Compare |
v11 | 2024-05-10 | French | Compare |
v10 | 2024-05-10 | English | Compare |
v9 | 2024-04-29 | French | Compare |
v8 | 2024-04-29 | English | Compare |
v7 | 2024-02-07 | French | Compare |
v6 | 2024-02-07 | English | Compare |
v5 | 2024-01-11 | French | Compare |
v4 | 2024-01-11 | English | Compare |
v3 | 2023-09-16 | English | Compare |
v2 | 2023-09-15 | French | Compare |
v1 | 2023-09-15 | English | Compare |
Showing 1 to 13 of 13